Q1 EPS Forecast for Agilent Technologies Lowered by Analyst

Agilent Technologies, Inc. (NYSE:A) – Stock analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for Agilent Technologies in a research note issued to investors on Wednesday, December 11th. Zacks Research analyst R. Department now expects that the medical research company will earn $1.27 per share for the quarter, down from their prior forecast of $1.38. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.56 per share. Zacks Research also issued estimates for Agilent Technologies’ Q2 2025 earnings at $1.33 EPS, Q4 2025 earnings at $1.55 EPS, FY2025 earnings at $5.55 EPS, Q1 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.58 EPS and FY2026 earnings at $6.10 EPS.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The company had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the company earned $1.38 earnings per share. The firm’s revenue for the quarter was up .8% on a year-over-year basis.

Several other research firms also recently issued reports on A. Evercore ISI increased their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. TD Cowen increased their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Citigroup boosted their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $151.00 price target on shares of Agilent Technologies in a report on Monday, August 26th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $143.14.

Agilent Technologies Stock Down 0.2 %

Shares of A opened at $140.90 on Friday. The firm has a market cap of $40.48 billion, a P/E ratio of 31.88, a PEG ratio of 4.46 and a beta of 1.07. Agilent Technologies has a 12 month low of $124.16 and a 12 month high of $155.35. The stock’s 50 day moving average is $136.95 and its two-hundred day moving average is $136.57. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.248 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 annualized dividend and a yield of 0.70%. Agilent Technologies’s dividend payout ratio is 22.40%.

Insider Buying and Selling at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.33% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Crewe Advisors LLC boosted its stake in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 101 shares in the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $28,000. Ridgewood Investments LLC purchased a new position in Agilent Technologies during the 2nd quarter worth approximately $29,000. Ashton Thomas Securities LLC purchased a new stake in Agilent Technologies in the third quarter valued at approximately $31,000. Finally, Fortitude Family Office LLC boosted its holdings in shares of Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 95 shares during the period. Hedge funds and other institutional investors own 87.42% of the company’s stock.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.